Micro-cap Losers: ReneSola Ltd. (NYSE:SOL), Hansen Medical, Inc. (NASDAQ:HNSN), iPass Inc. (NASDAQ:IPAS), CEL-SCI Corporation (NYSEMKT:CVM)

On May 06, 2014, ReneSola Ltd. (ADR) (NYSE:SOL), a leading brand and technology provider of solar photovoltaic (“PV”) products, announced it has been contracted to provide 1.6MW in solar modules and 1MW in mounting systems to Consolidated Energy & Economic Engineering Co. (“Consolidated Energy”) to power a series of residential and commercial rooftop projects in Jordan. ReneSola Ltd. (ADR) (NYSE:SOL), net profit margin is -17.10% and weekly performance is -11.15%. On last trading day company shares ended up $2.47. Analysts mean target price for the company is $4.13. ReneSola Ltd. (ADR) (NYSE:SOL), distance from 50-day simple moving average (SMA50) is -27.33%.

On May 07, 2014, Hansen Medical, Inc. (NASDAQ:HNSN), a global leader in intravascular robotics, reported recent business highlights and financial results for the first quarter of fiscal year 2014 ended March 31, 2014. Hansen Medical, Inc. (NASDAQ:HNSN), shares fell 25.28% in last trading session and ended the day on $1.33. HNSN, Gross Margin is 20.60% and its return on assets is -96.70%. Hansen Medical, Inc. (NASDAQ:HNSN), quarterly performance is -40.89%.

iPass Inc. (NASDAQ:IPAS), the global Wi-Fi roaming leader for enterprises and telecom service providers, announced financial results for the first quarter ended March 31, 2014. iPass Inc. (NASDAQ:IPAS), shares moved down 29.01% in last trading session and was closed at $1.15, while trading in range of $ 1.05 – 1.57. iPass Inc. (NASDAQ:IPAS), year to date (YTD) performance is -26.75%.

CEL-SCI Corporation (NYSEMKT:CVM), Product Pipeline Review – 2014 is a new market research publication announced by Reportstack. CEL-SCI Corporation (NYSEMKT:CVM), ended the last trading day at $1.08. Company weekly volatility is calculated as 7.90% and price to cash ratio as 5.37. CEL-SCI Corporation (NYSEMKT:CVM), showed a negative weekly performance of 13.60%.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *